Cabot Small-Cap Confidential Special Bulletin
Personalis (PSNL) released preliminary Q4 results on January 11 and the official release after the close yesterday offered no surprises. Personalis (PSNL) Moves To SELL
Read More
paying dividends Archives
Cabot Small-Cap Confidential Special Bulletin
Sprout Social (SPT) reported Q4 results yesterday that surpassed expectations. Revenue was up 32.6% to $37.3 million (beating by $1.4 million) while adjusted EPS of -$0.06 beat by $0.05. Guidance for 2021 looks solid with management calling for 2021 revenue of $172.5 million (up modestly...
Read More
Cabot Small-Cap Confidential Special Bulletin
Everbridge (EVBG) reported Q4 results yesterday that exceeded expectations on both the top and bottom lines and have sent shares soaring over 20% to a new all-time high this morning. Part of the reason is that the stock has been consolidating forever and is of...
Read More
Cabot Small-Cap Confidential Special Bulletin
Since reporting earnings earlier this week shares of Avalara (AVLR) have retreated modestly, despite a solid quarter. As I’ve flipped through dozens of charts over the last two days I’ve been struck by the diverging performance of earnings winners.
Read More
Cabot Small-Cap Confidential Special Bulletin
Avalara (AVLR) reported results after the close yesterday that handily beat expectations on virtually all metrics. Q4 revenue was up 35% to $144.8 million (beating by $11.4 million) while adjusted EPS of $0.09 beat by $0.15. Billings of $167 million were up 38%. Adjusted margin...
Read More
Cabot Dividend Investor 221
The Market Just Keeps on Going
The bull market keeps raging. All three major indexes just made still new all-time highs. The S&P 500 is up about 20% since the end of October and 78% since the low of last March. How long can keep...
Read More
Benjamin Graham’s Seven Criteria for Picking Value Stocks
Benjamin Graham was the father of value investing, and these were his seven primary criteria for selecting winning value stocks.
Read More
Cabot Small-Cap Confidential Special Bulletin
Cerence (CRNC) reported this morning that Q1 revenue was up 22.6% to $95 million (beating by $7.1 million) while adjusted EPS of $0.59 was up 103% (beating by $0.08). There are a lot of initiatives at Cerence and management had a lot to say, I’ll...
Read More
Cabot Undervalued Stocks Advisor 221
With the now-infamous Reddit trades unraveling, and the rebalancing done, the market is free to rebound.
Read More
Cabot Small-Cap Confidential Special Bulletin
Late yesterday Accolade (ACCD) announced it was diving deeper into the telehealth market by acquiring 2nd.MD, a small start-up based in Houston, TX. The acquisition target provides expert medical consultation services to patients, typically at a critical point in the patients’ lives when a second and/or...
Read More
Cabot Dividend Investor 121
A Goliath of the Dawning Digital Age
Are you sick of hearing about the virus and the election? I know I am. But there’s good news. As hard as it may be to believe, these current obsessions will fade away, and soon. As the from...
Read More
Cabot Small-Cap Confidential Special Bulletin
Karyopharm (KPTI) pre-announced Q4 2020 results yesterday morning and I watched the stock, which was weak (closed down 8%) throughout the day as I pondered the results. I’ll get to my thoughts in a minute. First, the numbers.
Read More
Cabot Small-Cap Confidential Special Bulletin
Yesterday after the close Accolade (ACCD) reported Q3 results that surpassed expectations on both the top and bottom lines.
Read More
Cabot Undervalued Stocks Advisor 121
Sometimes the most appealing stocks are those that superficially seem to go against trends (leading to investors avoiding them) yet have either fundamental traits that sidestep these trends or have overly discounted valuations.
Read More
The Best Investment Sites to Research Stocks
This list of the best investment sites to research stocks aims to help individual investors navigate the sea of stock-related information on the web.
Read More
Cabot Dividend Investor 1220
Profit from the Resurgence of the Banks
The vaccine is changing everything. Stocks that had been left for dead by the market recovery are springing back to life and leading the market higher.
A coronavirus vaccine could end the pandemic and usher in a full in...
Read More
Cabot Undervalued Stocks Advisor 1220
Stocks have surged this past month, with the S&P 500 returning 11% in November. Other major indices, including the Dow Jones Industrial Average and the Nasdaq Composite, produced similarly strong returns. These kinds of returns would make a good year in most investors’ eyes.
Read More
Cabot Small-Cap Confidential Special Bulletin
Tyler updates us on one more stock that reported earnings recently.
Read More
Cabot Small-Cap Confidential Special Bulletin
Tyler updates us on one more stock that reported earnings recently.
Read More
Cabot Dividend Investor 1120
The Promised Land Awaits
It has been an amazing week in the market. Events have transpired to leave the market approaching all-time historic highs. And it may be just the beginning.
In the past weeks and months there were two major risks holding the market the...
Read More
Enter Your Log In Credentials
- Lost your password? Create New Password
- No account? Sign up